Latest Asx Market News

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

Tivan Limited’s shares have been suspended at the company’s request pending a major joint venture announcement and its response to an ASX compliance query.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Tigers Realm Coal’s planned divestment of its Russian subsidiaries has hit significant regulatory roadblocks, resulting in a reduced sale price, increased exit tax, and suspension from ASX trading.

Sequoia Financial Group will release its half-year FY25 financial results on 27 February 2025, accompanied by an investor webinar hosted by its CEO and CFO.

DigitalX Limited has completed the placement of all shortfall shares from its recent rights issue, raising a total of approximately $5.09 million and attracting new supportive shareholders. The company is deploying these funds to expand revenue-generating staking activities within the digital asset space.

Altair Minerals unveils its strategic exploration projects in Peru's prolific Venatica copper belt and Australia's Olympic Domain, aiming to unlock major copper-gold deposits with a seasoned technical team at the helm.

Betashares Capital Ltd has announced the final distribution amounts for its suite of funds for the January 2025 period, outlining key dates and eligibility for unitholders.

Arrow Minerals Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could influence its market position.

Way 2 Vat Ltd's trading suspension is scheduled to end on 13 January 2025, coinciding with the announcement of a proposed capital raising that could reshape its financial outlook.